Annual FCF
-$91.71 M
+$28.20 M+23.52%
31 December 2023
Summary:
Adverum Biotechnologies annual free cash flow is currently -$91.71 million, with the most recent change of +$28.20 million (+23.52%) on 31 December 2023. During the last 3 years, it has fallen by -$575.00 thousand (-0.63%). ADVM annual FCF is now -7121.26% below its all-time high of -$1.27 million, reached on 31 December 2012.ADVM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$21.34 M
-$1.49 M-7.48%
30 September 2024
Summary:
Adverum Biotechnologies quarterly free cash flow is currently -$21.34 million, with the most recent change of -$1.49 million (-7.48%) on 30 September 2024. Over the past year, it has increased by +$3.06 million (+12.55%). ADVM quarterly FCF is now -502.74% below its all-time high of $5.30 million, reached on 30 June 2014.ADVM Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$86.06 M
+$3.06 M+3.44%
30 September 2024
Summary:
Adverum Biotechnologies TTM free cash flow is currently -$86.06 million, with the most recent change of +$3.06 million (+3.44%) on 30 September 2024. Over the past year, it has increased by +$2.79 million (+3.14%). ADVM TTM FCF is now -3429.21% below its all-time high of $2.58 million, reached on 30 June 2014.ADVM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.5% | +12.6% | +3.1% |
| 3 y3 years | -0.6% | +32.3% | +26.1% |
| 5 y5 years | -67.4% | -35.8% | -48.1% |
ADVM Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -0.6% | +25.4% | -14.4% | +39.5% | at high | +35.1% |
| 5 y | 5 years | -67.4% | +25.4% | -35.8% | +43.2% | -48.1% | +35.1% |
| alltime | all time | -7121.3% | +25.4% | -502.7% | +43.2% | -3429.2% | +35.1% |
Adverum Biotechnologies Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$21.34 M(+7.5%) | -$86.06 M(-3.4%) |
| June 2024 | - | -$19.86 M(-14.9%) | -$89.12 M(-3.7%) |
| Mar 2024 | - | -$23.34 M(+8.4%) | -$92.55 M(+0.9%) |
| Dec 2023 | -$91.71 M(-23.5%) | -$21.52 M(-11.8%) | -$91.71 M(+3.2%) |
| Sept 2023 | - | -$24.41 M(+4.8%) | -$88.85 M(-8.5%) |
| June 2023 | - | -$23.29 M(+3.5%) | -$97.07 M(-11.0%) |
| Mar 2023 | - | -$22.50 M(+20.6%) | -$109.10 M(-9.0%) |
| Dec 2022 | -$119.91 M(-2.5%) | -$18.66 M(-42.8%) | -$119.91 M(-8.8%) |
| Sept 2022 | - | -$32.63 M(-7.6%) | -$131.41 M(+0.9%) |
| June 2022 | - | -$35.31 M(+6.0%) | -$130.30 M(-1.7%) |
| Mar 2022 | - | -$33.30 M(+10.4%) | -$132.55 M(+7.8%) |
| Dec 2021 | -$122.95 M(+34.9%) | -$30.17 M(-4.3%) | -$122.95 M(+5.6%) |
| Sept 2021 | - | -$31.52 M(-16.1%) | -$116.44 M(+1.6%) |
| June 2021 | - | -$37.56 M(+58.4%) | -$114.56 M(+18.1%) |
| Mar 2021 | - | -$23.71 M(+0.2%) | -$97.02 M(+6.5%) |
| Dec 2020 | -$91.14 M(+33.2%) | -$23.66 M(-20.2%) | -$91.14 M(+0.5%) |
| Sept 2020 | - | -$29.63 M(+48.0%) | -$90.69 M(+18.1%) |
| June 2020 | - | -$20.02 M(+12.3%) | -$76.78 M(+8.4%) |
| Mar 2020 | - | -$17.83 M(-23.2%) | -$70.84 M(+3.5%) |
| Dec 2019 | -$68.42 M(+24.9%) | -$23.21 M(+47.6%) | -$68.42 M(+17.8%) |
| Sept 2019 | - | -$15.72 M(+11.6%) | -$58.10 M(-2.4%) |
| June 2019 | - | -$14.09 M(-8.6%) | -$59.55 M(+4.5%) |
| Mar 2019 | - | -$15.40 M(+19.5%) | -$56.98 M(+4.0%) |
| Dec 2018 | -$54.77 M | -$12.89 M(-24.9%) | -$54.77 M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$17.17 M(+49.1%) | -$54.18 M(+14.8%) |
| June 2018 | - | -$11.52 M(-12.8%) | -$47.18 M(-0.8%) |
| Mar 2018 | - | -$13.20 M(+7.4%) | -$47.56 M(+2.4%) |
| Dec 2017 | -$46.44 M(+13.9%) | -$12.30 M(+20.9%) | -$46.44 M(+7.0%) |
| Sept 2017 | - | -$10.17 M(-14.5%) | -$43.41 M(+0.4%) |
| June 2017 | - | -$11.89 M(-1.6%) | -$43.24 M(+6.6%) |
| Mar 2017 | - | -$12.08 M(+30.4%) | -$40.58 M(-0.5%) |
| Dec 2016 | -$40.78 M(+6.4%) | -$9.27 M(-7.4%) | -$40.78 M(-0.1%) |
| Sept 2016 | - | -$10.01 M(+8.5%) | -$40.83 M(-1.3%) |
| June 2016 | - | -$9.23 M(-24.8%) | -$41.36 M(-2.6%) |
| Mar 2016 | - | -$12.28 M(+31.8%) | -$42.45 M(+10.8%) |
| Dec 2015 | -$38.33 M(+481.6%) | -$9.31 M(-11.6%) | -$38.33 M(+11.3%) |
| Sept 2015 | - | -$10.54 M(+2.1%) | -$34.44 M(+18.8%) |
| June 2015 | - | -$10.32 M(+26.6%) | -$28.97 M(+117.0%) |
| Mar 2015 | - | -$8.15 M(+50.5%) | -$13.35 M(+102.5%) |
| Dec 2014 | -$6.59 M(+190.9%) | -$5.42 M(+6.7%) | -$6.59 M(+246.5%) |
| Sept 2014 | - | -$5.08 M(-195.8%) | -$1.90 M(-173.6%) |
| June 2014 | - | $5.30 M(-480.2%) | $2.58 M(-175.2%) |
| Mar 2014 | - | -$1.39 M(+91.0%) | -$3.44 M(+51.7%) |
| Dec 2013 | -$2.27 M(+78.4%) | -$730.00 K(+23.5%) | -$2.27 M(+47.5%) |
| Sept 2013 | - | -$591.00 K(-18.3%) | -$1.54 M(+62.5%) |
| June 2013 | - | -$723.00 K(+225.7%) | -$945.00 K(+325.7%) |
| Mar 2013 | - | -$222.00 K | -$222.00 K |
| Dec 2012 | -$1.27 M | - | - |
FAQ
- What is Adverum Biotechnologies annual free cash flow?
- What is the all time high annual FCF for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual FCF year-on-year change?
- What is Adverum Biotechnologies quarterly free cash flow?
- What is the all time high quarterly FCF for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly FCF year-on-year change?
- What is Adverum Biotechnologies TTM free cash flow?
- What is the all time high TTM FCF for Adverum Biotechnologies?
- What is Adverum Biotechnologies TTM FCF year-on-year change?
What is Adverum Biotechnologies annual free cash flow?
The current annual FCF of ADVM is -$91.71 M
What is the all time high annual FCF for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual free cash flow is -$1.27 M
What is Adverum Biotechnologies annual FCF year-on-year change?
Over the past year, ADVM annual free cash flow has changed by +$28.20 M (+23.52%)
What is Adverum Biotechnologies quarterly free cash flow?
The current quarterly FCF of ADVM is -$21.34 M
What is the all time high quarterly FCF for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly free cash flow is $5.30 M
What is Adverum Biotechnologies quarterly FCF year-on-year change?
Over the past year, ADVM quarterly free cash flow has changed by +$3.06 M (+12.55%)
What is Adverum Biotechnologies TTM free cash flow?
The current TTM FCF of ADVM is -$86.06 M
What is the all time high TTM FCF for Adverum Biotechnologies?
Adverum Biotechnologies all-time high TTM free cash flow is $2.58 M
What is Adverum Biotechnologies TTM FCF year-on-year change?
Over the past year, ADVM TTM free cash flow has changed by +$2.79 M (+3.14%)